Related Experiment Video
Updated: Aug 13, 2026

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Cromolyn effects on vernal keratoconjunctivitis in children
Insights
Topical cromolyn sodium eye drops effectively treated vernal keratoconjunctivitis symptoms in children. Long-term use of this treatment showed no adverse side effects, offering a safe therapeutic option.
Area of Science:
- Ophthalmology
- Allergology
- Pediatric Medicine
Background:
- Vernal keratoconjunctivitis (VKC) is a severe allergic eye condition affecting children.
- Current treatments for VKC can have limitations or side effects.
- Evaluating safe and effective long-term therapies for VKC is crucial.
Purpose of the Study:
- To assess the efficacy and safety of 2% cromolyn sodium eye drops in treating pediatric VKC.
- To compare the effects of cromolyn sodium against a placebo in a controlled trial.
Main Methods:
- A double-masked, randomized, placebo-controlled trial involving 14 children with VKC.
- One eye of each child was treated with 2% cromolyn sodium eye drops, while the other received a placebo.
- Treatment duration was one year.
Main Results:
- Cromolyn sodium significantly reduced vernal keratitis, corneal ulcers, plaques, and limbal edema/infiltrates.
- The number and size of giant papillae were not affected by cromolyn sodium treatment.
- No adverse side effects were observed with long-term topical cromolyn sodium use.
Conclusions:
- Topical 2% cromolyn sodium eye drops are an effective treatment for several key symptoms of VKC in children.
- Cromolyn sodium demonstrates a favorable safety profile for extended use in pediatric VKC management.
- This study supports cromolyn sodium as a viable therapeutic option for managing pediatric vernal keratoconjunctivitis.
Abstract:
A double-masked, coded trial was undertaken to evaluate the effect of the topical administration of 2% cromolyn sodium eye drops on vernal keratoconjunctivitis in 14 children. One eye of each patient was treated for one year with cromoly, the other eye with placebo. Cromolyn reduced the characteristic vernal keratitis, vernal corneal ulcers and plaques, and limbal edema and infiltrates but did not affect the number or size of the giant papillae. The drug's long-term topical use did not have any adverse side effects.
Related Concept Videos
Allergic Drug Reactions
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

